Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07644000
Effect of Pre-exercise Inhalation of Molecular Hydrogen on Metabolic Response During Graded Exercise in Healthy WomenPalacky UniversityNot Yet RecruitingNot Applicable
NCT07644000Not Yet Recruiting
Not Applicable
Effect of Pre-exercise Inhalation of Molecular Hydrogen on Metabolic Response Du...Palacky University
NCT07644247
STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD PumpBeijing Anzhen HospitalNot Yet RecruitingPhase 4
NCT07644247Not Yet Recruiting
Phase 4
STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitat...Beijing Anzhen Hospital
NCT07644676
The Impact of Adhesion Strategy on the Clinical Performance Of Indirect Dental RestorationsMalmö UniversityEnrolling By InvitationNot Applicable
NCT07644676Enrolling By Invitation
Not Applicable
The Impact of Adhesion Strategy on the Clinical Performance Of Indirect Dental R...Malmö University
NCT07645807
An Investigator-Initiated, Randomized, Double-Blind, Double-Dummy Study to Evaluate the Adjunctive Effect of CreNeuroS™ CNS Fish Oil Plus Softgels in Patients With Major Depressive Disorder Receiving Escitalopram.Sichuan Credit Pharmaceutical Co., Ltd.Not Yet RecruitingNot Applicable
NCT07645807Not Yet Recruiting
Not Applicable
An Investigator-Initiated, Randomized, Double-Blind, Double-Dummy Study to Evalu...Sichuan Credit Pharmaceut...
NCT07646418
Combined Effects of LIRT-BFR Therapy in Post- Stroke PatientsRiphah International UniversityRecruitingNot Applicable
NCT07646418Recruiting
Not Applicable
Combined Effects of LIRT-BFR Therapy in Post- Stroke PatientsRiphah International Univ...
NCT07645092
Vertebral Augmentation and Percutaneous Fixation for Thoracolumbar Burst Fractures Requiring CorpectomyUniversity Hospital, GrenobleNot Yet Recruiting
NCT07645092Not Yet Recruiting
—
Vertebral Augmentation and Percutaneous Fixation for Thoracolumbar Burst Fractur...University Hospital, Gren...
NCT07645846
Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal CarcinomaFirst Affiliated Hospital, Sun Yat-Sen UniversityNot Yet RecruitingPhase 2
NCT07645846Not Yet Recruiting
Phase 2
Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal CarcinomaFirst Affiliated Hospital...
NCT07643779
Symptom Severity, Posture, Pain, and Physical Activity in Gastroesophageal Reflux DiseaseKarabuk UniversityNot Yet Recruiting
NCT07643779Not Yet Recruiting
—
Symptom Severity, Posture, Pain, and Physical Activity in Gastroesophageal Reflu...Karabuk University
NCT07646535
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary AldosteronismShenzhen Salubris Pharmaceuticals Co., Ltd.Not Yet RecruitingPhase 2
NCT07646535Not Yet Recruiting
Phase 2
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses i...Shenzhen Salubris Pharmac...
NCT07644780
Evaluation of an Intervention for Optimizing Pregnant Women's Adherence to Maternal Multiple Micronutrients SupplementsNutrition InternationalCompletedNot Applicable
NCT07644780Completed
Not Applicable
Evaluation of an Intervention for Optimizing Pregnant Women's Adherence to Mater...Nutrition International
NCT07644741
Load-Matched Unilateral Versus Bilateral Squat Training in Elite Youth Futsal PlayersFederal University of VicosaCompletedNot Applicable
NCT07644741Completed
Not Applicable
Load-Matched Unilateral Versus Bilateral Squat Training in Elite Youth Futsal Pl...Federal University of Vic...
NCT07646028
R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS)Rise Therapeutics LLCNot Yet RecruitingPhase 1
NCT07646028Not Yet Recruiting
Phase 1
R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS)Rise Therapeutics LLC
NCT07644403
Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.Suzhou Immunofoco Biotechnology Co., LtdEnrolling By InvitationPhase 1
NCT07644403Enrolling By Invitation
Phase 1
Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid...Suzhou Immunofoco Biotech...
NCT07645469
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid LeukemiaFred Hutchinson Cancer CenterNot Yet RecruitingPhase 1
NCT07645469Not Yet Recruiting
Phase 1
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Di...Fred Hutchinson Cancer Ce...
NCT07643818
Intravenous Iron to Improve Symptoms, Quality of Life and Exercise Capacity in HFpEF With Iron DeficiencyGovernment of JerseyNot Yet RecruitingPhase 2
NCT07643818Not Yet Recruiting
Phase 2
Intravenous Iron to Improve Symptoms, Quality of Life and Exercise Capacity in H...Government of Jersey
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07644013
Prospective Multicenter Registry Study of Multiple System Atrophy in ChinaPeking University First HospitalRecruiting
NCT07644013Recruiting
—
Prospective Multicenter Registry Study of Multiple System Atrophy in ChinaPeking University First H...
NCT07646171
EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)Tel-Aviv Sourasky Medical CenterRecruiting
NCT07646171Recruiting
—
EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+)...Tel-Aviv Sourasky Medical...
NCT07645287
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1Gilead SciencesNot Yet RecruitingPhase 2
NCT07645287Not Yet Recruiting
Phase 2
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologica...Gilead Sciences
Result Breakdown
Not yet recruiting11 (55%)
Recruiting4 (20%)
Completed3 (15%)
Enrolling by invitation2 (10%)
not_applicable6 (30%)
Phase 25 (25%)
Not Specified4 (20%)
Phase 14 (20%)
Phase 41 (5%)